UPMC CancerCenter is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.
UPMC CancerCenter has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Hematological Malignancies, Metastatic Merkel Cell Carcinoma, Unresectable or Metastatic Solid Tumors.
Sponsors: Kangpu Biopharmaceuticals, Ltd., Incyte Corporation, Chimagen Biosciences, Ltd.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Pittsburgh
Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC CancerCenter has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC CancerCenter has 6 clinical trials on record, with 1 currently active. Their work covers Hematological Malignancies, Metastatic Merkel Cell Carcinoma, Unresectable or Metastatic Solid Tumors.
UPMC CancerCenter has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.